Biogen Inc. (BIIB) News Headlines

▮ More

Date

Headline

9/17/2021 9:51:39 AM Biogen Announces Positive CHMP Opinion For VUMERITY - Quick Facts

9/17/2021 9:37:30 AM Biogen : CHMP Recommends VUMERITY For Approval In EU As Treatment For RRMS

9/16/2021 8:37:23 AM Biogen Announces Positive Results From Phase 2 Study Of Vixotrigine In Small Fiber Neuropathy

9/16/2021 7:35:42 AM Biogen Announces Positive Topline Results From Phase 2 CONVEY Study In Small Fiber Neuropathy

9/9/2021 3:42:10 PM Biogen Admits To "Slower Than Anticipated" Launch Of Its Alzheimer's Drug

8/30/2021 2:43:24 AM Biotech Stocks Facing FDA Decision In September 2021

8/2/2021 8:42:57 AM Biogen: Every Six-week Natalizumab Administration Provides High Level Of Efficacy In Controlling MS

8/2/2021 7:40:04 AM Biogen Announces Results From Phase 3b NOVA Study Evaluating Natalizumab In Relapsing-Remitting Multiple Sclerosis

7/26/2021 10:40:16 PM Biogen : Phase 1b Study On Alzheimer's Disease Meets Primary Objective Of Safety & Tolerability

7/22/2021 8:00:33 AM Biogen Inc. (BIIB) Has Raised Its FY21 Revenue Estimate To $10.65 - $10.85 Bln From $10.45 - $10.75 Bln

7/22/2021 7:33:26 AM Biogen Boosts FY21 Revenue Outlook; Q2 Results Top Estimates - Quick Facts

7/22/2021 7:12:54 AM Biogen Q2 GAAP EPS $2.99; Non-GAAP EPS $5.68

7/22/2021 7:04:13 AM Biogen Q2 21 Earnings Conference Call At 8:00 AM ET

7/21/2021 8:04:33 AM Mirimus, Biogen To Develop RNAi-Based Therapeutics For Neurological Disease Indications

7/9/2021 5:51:49 PM FDA Calls For Investigation Into Approval Of Biogen's Alzheimer's Drug

7/8/2021 8:01:33 AM Biogen Says FDA Approves Updated Label For Alzheimer's Drug Aduhelm Injection - Quick Facts

6/29/2021 9:41:34 AM Enel X Partners Biogen To Electrify Its Employee Commercial Fleet - Quick Facts

6/29/2021 9:05:20 AM Enel X Supporting Biogen In Its Goal To Achieve Fleet Electrification Of Over 1,000 Vehicles In North America By 2025

6/25/2021 7:51:52 AM Samsung Bioepis, Biogen Get Positive CHMP Opinion For Ranibizumab Biosimilar BYOOVIZ - Quick Facts

6/17/2021 7:37:44 AM Biogen Doses First Patient In Phase 3 Study Evaluating Efficacy And Safety Of BIIB059 In Systemic Lupus Erythematosus